Sign up online today & collaborate
or click here to find out more
Aquila Biomedical is now working in the area of immune oncology.
A BioQuarter spin-out facilitated by the Team, Aquila offers specialist drug discovery biological models. The company's original focus was in autoimmunity. But a recent move to focus on immune oncology has created the opportunity of discovering new therapies that can harness the capabilities of the immune system to remove cancer cells which had previously developed methods to evade the body's defence cells
February edition of IQ for Sunergos Innovations